Healthy volunteers test new Drug's safety and food interactions
NCT ID NCT06741345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the safety of BIO 300 Oral Suspension in 56 healthy adults aged 18-64. Participants received daily doses for 14 days or a single dose with or without food to see how the drug behaves in the body. The goal was to check for side effects and understand how food affects drug absorption, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network, LLC
Saint Paul, Minnesota, 55114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New asthma drug candidate enters first human safety tests
- Variety beats repetition: study shows mixing it up improves motor learning
- Pain-Free shots? study tests if preservative is the culprit
- Scientists deliberately infect volunteers with whooping cough to study natural defenses
- Could a nerve channel blocker replace opioids? early study investigates
- New pain pill takes first step: safe in healthy volunteers?